NANOPARTICLE AS THE STRATEGY FOR THE DEVELOPMENT OF SARS-COV-2 ANTIVIRAL DRUGS

In just a matter of months, SARS-CoV-2 had spread around the world. Scientists collaborate to solve problem. The development antiviral drugs is challenge in itself due rapidly changing nature virus. Selection drug candidates can be done quickly through repurposing method. Broad-spectrum may strong for therapy. Nanotechnology one solution delivery systems. advantages possessed by nanoparticle system answer need an ideal drug. This article will focus on preparations as strategy handling viruses, including SARS-CoV-2. selection current review was searched from specialized databases such Elsevier, Pubmed, Science Direct, Medscape and other credible using keywords nanoparticle, SARS-CoV-2, Covid-19, repurposing, polymeric micelle, liposome, solid lipid nanostructured carrier, dendrimer, metallic nanoparticle. range articles 2007–2021.